Form 8-K Werewolf Therapeutics, For: Aug 14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
Werewolf Therapeutics sells platform assets to EMD Serono for $33M
August 20, 2026 4:12 PM EDTWerewolf Therapeutics (NASDAQ: HOWL) sold its pre-clinical INDUCER platform and portions of its INDUKINE platform to EMD Serono Research & Development Institute Inc. on Aug. 14, 2026, under an asset purchase agreement.
Under the terms of the agreement, EMD Serono agreed to pay $28.0 million upfront, with... More



